{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:10:13Z","timestamp":1787980213373,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.chest.2022.12.027","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T20:27:22Z","timestamp":1672864042000},"page":"1458-1470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5237-1397","authenticated-orcid":false,"given":"Anushka K.","family":"Palipana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-4922","authenticated-orcid":false,"given":"Emrah","family":"Gecili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongho","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9837-2763","authenticated-orcid":false,"given":"Simon R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda D.","family":"Szczesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9112-1315","authenticated-orcid":false,"given":"Nishant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2022.12.027_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2022.12.027_bib2","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1164\/rccm.201411-2094CI","article-title":"Diffuse cystic lung disease. Part I","volume":"191","author":"Gupta","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2022.12.027_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ajmg.c.31638","article-title":"Pulmonary manifestations in tuberous sclerosis complex","volume":"178","author":"Gupta","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"10.1016\/j.chest.2022.12.027_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","article-title":"The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis","volume":"155","author":"Gupta","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2022.12.027_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"issue":"10","key":"10.1016\/j.chest.2022.12.027_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2011-200953","article-title":"Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study","volume":"67","author":"Taylor-Robinson","year":"2012","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.chest.2022.12.027_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.annepidem.2013.08.009","article-title":"A\u00a0semiparametric approach to estimate rapid lung function decline in cystic fibrosis","volume":"23","author":"Szczesniak","year":"2013","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.chest.2022.12.027_bib8","doi-asserted-by":"crossref","unstructured":"Su W, Gecili E, Wang X, Szczesniak RD. An empirical comparison of segmented and stochastic linear mixed effects models\u00a0to estimate rapid disease progression in longitudinal biomarker studies, Stat Biopharm Res, 2021.13(3):270-279","DOI":"10.1080\/19466315.2020.1870546"},{"issue":"2","key":"10.1016\/j.chest.2022.12.027_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.chest.2022.12.027_bib10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2022.12.027_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/sim.8443","article-title":"Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression","volume":"39","author":"Szczesniak","year":"2020","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.chest.2022.12.027_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2022.12.027_bib13","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","article-title":"Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An official American Thoracic Society\/Japanese Respiratory Society clinical practice guideline","volume":"196","author":"Gupta","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2022.12.027_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03036-2020","article-title":"Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis","volume":"57","author":"Chernbumroong","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2022.12.027_bib15","doi-asserted-by":"crossref","first-page":"j2250","DOI":"10.1136\/bmj.j2250","article-title":"Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards","volume":"357","author":"Dehbi","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.chest.2022.12.027_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0167-9473(95)00057-7","article-title":"Partially parametric techniques for multiple imputation","volume":"22","author":"Schenker","year":"1996","journal-title":"Computational Statistics & Data Analysis"},{"issue":"3","key":"10.1016\/j.chest.2022.12.027_bib17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/biostatistics\/kxu053","article-title":"Real-time monitoring of progression towards renal failure in primary care patients","volume":"16","author":"Diggle","year":"2015","journal-title":"Biostatistics"},{"issue":"427","key":"10.1016\/j.chest.2022.12.027_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/01621459.1994.10476806","article-title":"A\u00a0Stochastic model for analysis of longitudinal AIDS data","volume":"89","author":"Taylor","year":"1994","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.chest.2022.12.027_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ije\/dyu262","article-title":"Joint modelling of repeated measurement and time-to-event data: an introductory tutorial","volume":"44","author":"Asar","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.chest.2022.12.027_bib20","first-page":"1","article-title":"The R package JMbayes for fitting joint models for longitudinal and time-to-event data using MCMC","volume":"72","author":"Rizopoulos","year":"2016","journal-title":"J\u00a0Stat Softw"},{"issue":"4","key":"10.1016\/j.chest.2022.12.027_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02066-2018","article-title":"Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis","volume":"53","author":"Gupta","year":"2019","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2022.12.027_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.resinv.2015.11.003","article-title":"Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: an analysis of the Japanese National Research Project on Intractable Diseases database","volume":"54","author":"Hayashida","year":"2016","journal-title":"Respir Invest"},{"issue":"6","key":"10.1016\/j.chest.2022.12.027_bib23","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2022.12.027_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2022.12.027_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/thoraxjnl-2021-217809","article-title":"Disease monitoring using lung function trajectory in lymphangioleiomyomatosis: assessment in two national cohorts","volume":"78","author":"Johnson","year":"2023","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.chest.2022.12.027_bib26","doi-asserted-by":"crossref","first-page":"00102","DOI":"10.1183\/23120541.00102-2015","article-title":"Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective","volume":"2","author":"Bassi","year":"2016","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.chest.2022.12.027_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1440-1843.2007.01101.x","article-title":"The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors","volume":"12","author":"Hayashida","year":"2007","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.chest.2022.12.027_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00088314","article-title":"Severity and outcome of cystic lung disease in women with tuberous sclerosis complex","volume":"45","author":"Taveira-DaSilva","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2022.12.027_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105993","article-title":"Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis","volume":"168","author":"Di Marco","year":"2020","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2022.12.027_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1513\/AnnalsATS.201807-471RL","article-title":"Lymphangioleiomyomatosis mortality in patients with tuberous sclerosis complex","volume":"16","author":"Zak","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2022.12.027_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1214\/10-STS330","article-title":"To explain or to predict?","volume":"25","author":"Shmueli","year":"2010","journal-title":"Stat Sci"},{"issue":"6","key":"10.1016\/j.chest.2022.12.027_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","article-title":"Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial","volume":"1","author":"Young","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2022.12.027_bib34","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/ajrccm.164.6.2102125","article-title":"Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis","volume":"164","author":"Taveira-DaSilva","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2022.12.027_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000478-200104000-00007","article-title":"Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score","volume":"25","author":"Matsui","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.chest.2022.12.027_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry","volume":"191","author":"Oprescu","year":"2013","journal-title":"Lung"},{"issue":"11","key":"10.1016\/j.chest.2022.12.027_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/21678707.2017.1391089","article-title":"Sirolimus for the treatment of lymphangioleiomyomatosis","volume":"5","author":"Singla","year":"2017","journal-title":"Expert Opin Orphan Drugs"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:41:34Z","timestamp":1727300494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0012369223000065"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.12.027","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}